Member Exclusive

Chronic heart failure clinical trial: mesenchymal stem cell therapy safety & viability reported

A Phase IIa clinical trial utilizing intravenous administration of mesenchymal stem cells in cardiac patients has reported positive safety and efficacy results.

Go to the profile of RegMedNet
Sep 02, 2016

Please sign in or register for FREE

No comments yet.